U.S. Pharma Stock News

Some investors may be wondering whether Alaska Air Group at around US$36.78 is starting to look interesting again, or if the market is still pricing in too much risk. The stock has seen a 4.4% decline over the last week, a 28.7% fall over the past month, and a 25.0% decline over the last year, which can change how the market views both its potential and its risk profile. These moves sit against a longer backdrop where the shares are down 12.4% over three years and 50.1% over five years. That...

In recent weeks, Carrier Global reported a 6% year-on-year revenue decline that missed analyst estimates, lowered its 2025 guidance amid persistent residential HVAC weakness, and announced a smaller-than-anticipated 6.7% dividend increase, while its venture arm invested in UK-based Heat Geek to support AI-enabled residential heat pump adoption across Europe. These developments highlight a growing tension between Carrier’s pressure in interest-rate-sensitive residential markets and its push...

Recent coverage of IAC’s portfolio of digital businesses, including Dotdash Meredith, Angi, and Care.com, has underscored flat sales over five years alongside earnings per share falling about 19.1% annually, pointing to weaker profitability and negative returns on capital. This deterioration in returns suggests that some of IAC’s growth initiatives may be destroying, rather than creating, value, raising fresh questions about how effectively its capital is being deployed. Next, we’ll examine...

Why the GrayMatter Robotics partnership matters for Huntington Ingalls Industries stock Huntington Ingalls Industries (HII) is putting physical AI in the spotlight, with an upcoming memorandum of understanding signing and live technology demonstrations at GrayMatter Robotics’ headquarters on April 6 drawing fresh attention to the stock. See our latest analysis for Huntington Ingalls Industries. HII’s share price has eased recently, with a 14.54% 1 month share price return and a 5.52% 7 day...

Allient (ALNT) is drawing investor attention after recent trading left the shares around $59.09, with a market cap near $1.01b. This has prompted closer scrutiny of its motion control business and recent return profile. See our latest analysis for Allient. Recent trading has been choppy, with a 1-day share price decline of 0.72% and a 7-day and 30-day share price pullback of 9.18% and 10.25%, even as the 1-year total shareholder return stands at 169.33%, hinting at strong longer term...

Recently, aerospace and industrial controls company Woodward saw sentiment improve as reports emerged that President Trump was considering de-escalating military hostilities in Iran, alongside stabilizing oil prices and a broader market rebound. This shift in geopolitical risk perception temporarily eased investor concerns about potential disruption to industrial operations, highlighting how sensitive Woodward’s outlook can be to changes in global conflict and energy conditions. With...

Associated Wholesale Grocers, Inc. and Symbotic Inc. announced a past agreement to deploy Symbotic’s next-generation warehouse automation across 114,000 square feet at AWG’s Gulf Coast Division Support Center in Pearl River, Louisiana, aiming to process nearly 19 million dry-grocery cases annually once live in late 2027. The AWG project underlines how Symbotic’s automation platform is being used to convert fully manual, labor-constrained grocery distribution into higher-density, more...

Why recent headlines may not tell you the full story on Stride Stride attracts a lot of attention from investors wondering if the current share price reflects its underlying value or if there is a disconnect to unpack. The stock closed at US$88.17 recently, with returns of 1.6% over 7 days, 4.5% over 30 days, 36.5% year to date and a 31.7% decline over the last 12 months, while the 3 year and 5 year returns sit at 129.3% and 167.7% respectively. Recent news coverage has focused on Stride's...

Walt Disney (DIS) is back in focus after Disneyland Paris opened the World of Frozen expansion and reintroduced its second gate as Disney Adventure World, alongside record operating income from the company’s streaming segment. See our latest analysis for Walt Disney. Despite the positive headlines around World of Frozen and record streaming operating income, Disney’s recent share price performance has been weaker, with a 30 day share price return of 9.11% and a 1 year total shareholder return...

Apple (AAPL) is back in focus as investors weigh its current share price of US$253.79 against recent performance, including a one-month return of a 4% decline and a three-month return of a 7% decline. See our latest analysis for Apple. Over the past year, Apple’s share price return has softened in recent months, with a 30 day decline of 3.93% and a 90 day decline of 6.65%. At the same time, the 1 year total shareholder return of 14.21% and 5 year total shareholder return of 106.45% show that...

Missiles struck the Neot Hovav industrial zone in Israel, home to one of NYSE:TEVA’s largest manufacturing facilities. Emergency responses were triggered as authorities assessed damage and safety risks across the zone. Initial indications point to limited direct damage to Teva’s operations, but the incident highlighted exposure to geopolitical and physical threats. The event raised questions about operational continuity, supply chain reliability, and regulatory oversight for sites handling...

Tanger stock responds to recent trading performance Tanger (SKT) has drawn attention after a recent 8.3% decline over the past month, along with a modest 1.8% gain over the past 3 months. This has prompted investors to reassess the outlet mall REIT’s current positioning. See our latest analysis for Tanger. Zooming out, the recent 8.3% one month share price pullback sits against a 2.63% year to date share price return and a much stronger 160.21% five year total shareholder return. This...

The FDA has questioned Iovance Biotherapeutics (IOVA) over promotional materials for its skin cancer treatment Amtagvi, arguing that references to overall survival data could mislead clinicians and patients about the therapy's effectiveness. See our latest analysis for Iovance Biotherapeutics. The latest FDA scrutiny arrives after a strong 90 day share price return of 28.57% and a year to date share price return of 39.29%. However, the 1 year total shareholder return of 8.00% and 3 year total...

ServiceNow (NOW) is back in focus after a rebound that reflects investors reassessing earlier AI disruption worries, helped by stronger market sentiment, easing geopolitical tensions, and confidence in the company’s AI focused workflow automation partnerships and products. See our latest analysis for ServiceNow. Even with the recent rebound, ServiceNow’s share price is still reflecting a 30 day return of 3.2% and a year to date share price return of 29.1% in the red. The 1 year total...

What ARMOUR Residential REIT’s Recent Returns Tell You ARMOUR Residential REIT (ARR) has seen mixed share performance recently, with a 3.3% gain over the past day and 4.3% over the past week, but a 7.1% decline over the past month. See our latest analysis for ARMOUR Residential REIT. At a share price of $16.68, ARMOUR Residential REIT’s recent 1 day and 7 day share price gains sit against a weaker year to date share price return and a positive 1 year total shareholder return. This points to...

Ciena (NYSE:CIEN) is supplying its WaveLogic 6 Extreme technology to power a major transport network upgrade for Vodafone Idea (Vi) in India. The deployment supports industry first 1.6Tb/s connections on Vi’s network and enables up to 800G services for high bandwidth traffic. This rollout is aimed at supporting India’s rising data consumption and strengthening Vi’s core transport infrastructure. Ciena, a networking systems and software company, is expanding its footprint in India through...

If you are wondering whether V.F at around US$16.99 is a bargain or a trap, the answer comes down to what you think its current price really reflects. The stock has had a mixed run, with a 12.5% decline over the last 30 days but an 8.0% return over the past year, which can signal changing views on both its potential and its risks. Recent headlines around V.F have focused on its long term share price performance, including a 17.0% annualized decline over three years and a 76.0% decline over...

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...

FREELANDER, a new premium electric vehicle brand, has launched globally with Qualcomm technology at its core. The partnership focuses on advanced assisted driving systems and intelligent cabin features powered by Qualcomm platforms. The reveal highlights Qualcomm’s push into automotive and AI applications beyond its traditional handset business. For investors watching NasdaqGS:QCOM, the FREELANDER launch puts a spotlight on Qualcomm’s efforts to grow in automotive and AI driven use cases...

Six Flags Entertainment Corporation recently appointed Richard “Dick” Haddrill as Executive Chairman of its Board, with Marilyn Spiegel becoming Lead Independent Director, marking a leadership shift aimed at improving profitability and long-term growth. Haddrill’s track record of driving transformation at entertainment and gaming companies introduces a new level of operational focus that could meaningfully influence Six Flags’ future direction. Next, we’ll examine how Haddrill’s emphasis on...

Ondas Inc. recently reported full-year 2025 results, with sales rising to US$50.73 million from US$7.19 million while net loss widened to US$132.02 million, alongside the launch of ONBERG Autonomous Systems, a joint venture with Heidelberg to deliver drone defense and security systems in Europe. This combination of rapid revenue expansion, deeper defense collaboration in Germany and Ukraine, and continued losses has intensified questions about how Ondas balances growth ambitions with...

Moderna (MRNA) is back in focus after leadership promoted its so called Moderna 2.0 pivot toward oncology and individualized cancer therapy, paired with a multibillion dollar legal settlement that removed a major overhang. See our latest analysis for Moderna. The share price has climbed strongly over the past year, with a 90 day share price return of 72.26% and 1 year total shareholder return of 87.04%. However, the 3 year total shareholder return of a 67.54% decline shows how much earlier...

On March 27, 2026, Irenic Capital Management sent a public letter to Teleflex’s Board criticizing its refusal to engage with multiple credible acquisition interests and calling for board changes, a new Chair, and independent advisors to evaluate strategic alternatives. The letter highlights concerns about sustained value destruction, temporary leadership, and weak board-shareholder alignment, raising pressure on Teleflex to consider governance reforms and potential transaction...

In recent years, Fidelis Insurance Holdings has grown its revenue but seen expenses rise as a share of that income, causing a sharp reduction in pre-tax profit margins and a fall in earnings per share. This shift suggests that new business has been less profitable than before, raising questions about the quality and sustainability of Fidelis’s expansion. We will now examine how rising expenses and weaker margins may alter Fidelis Insurance Holdings’ investment narrative and longer-term...